Intranasal Oxytocin to Promote Weight Loss in Children and Adolescents With Brain Tumors and Hypothalamic Obesity Syndrome

Trial Profile

Intranasal Oxytocin to Promote Weight Loss in Children and Adolescents With Brain Tumors and Hypothalamic Obesity Syndrome

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2017

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 01 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top